SS
Serge Saxonov (Chief Executive Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $2.0M of TXG (24,000 sh across 4 lots, as filed), executed Sep 22. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.3M
shares × price, as filed
Last traded
Sep 22
Filed Sep 24
Median ADV $190.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
TXGRecent filings
TXGSALE
10x Genomics, Inc.
View filing →
$179K9,632 sh × $18.58
Exec Feb 23
Filed Feb 25 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $252K
13,261 sh × $19.00
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $129K
9,348 sh × $13.79
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET